XyloCor Therapeutics is a clinical-stage biopharmaceutical company headquartered in King of Prussia, Pennsylvania, focused on developing novel gene therapies for advanced…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see XyloCor Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks XyloCor Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.